002030.SZ
002030.SZ
CNE000001KP1
DAJY
Loading chart...

Company Profile

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers PCR testing kits, including hepatitis virus, human papillomavirus (HPV), sexually transmitted infections sexually transmitted infections, human immunodeficiency virus, blood screening, respiratory infections, digestive pathogens, public health, coronavirus disease (COVID-19), tumor marker, pharmacogenomics, nucleic acid extraction, and viral transport medium (VTM) collection kits. It also provides molecular diagnostic instruments comprising PCR detection systems, nucleic acid extraction systems, and sample transfer processing systems. In addition, the company offers immunoassay test kits that include COVID-19 rapid test kits; pathology tests, such as liquid based cytology production and automatic sample transfer machines; and auto biochemistry analyzers. It sells its products under the Daan Gene, Darui Biology, LBP, and Zhongshan Bio-Tech brands. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. Daan Gene Co., Ltd. was incorporated in 1988 and is headquartered in Guangzhou, China.

Related stocks

1952.HK
1952.HK • China
EVEREST MED
29.6 HKD
1.33B USD 1Y -47.1%
2595.HK
2595.HK • China
GENFLEET-B
28.6 HKD
1.4B USD 1Y -21%
688739.SS
688739.SS • China
LIAONING CHENGDA BIOTECHNOLOGY
21.2 CNY
1.32B USD 1Y -21.9%
9887.HK
9887.HK • China
LEADS BIOLABS-B
45.56 HKD
1.15B USD 1Y -37.5%
000403.SZ
000403.SZ • China
PLBIO
9.96 CNY
1.42B USD 1Y -39.1%
688177.SS
688177.SS • China
BIO THERA SOLUTIONS LTD
19.3 CNY
1.2B USD 1Y -31.6%
000990.SZ
000990.SZ • China
CHENGZHI
6.41 CNY
1.17B USD 1Y +22.1%
300294.SZ
300294.SZ • China
BOYA BIOLOGY
14.88 CNY
1.12B USD 1Y -40.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
38.6% p.a.
Max Drawdown (5Y)
-79.4%
Sharpe Ratio (5Y)
-0.58
Beta Factor
0.45
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -84.0% in the extended horizon.
ende